AIDS strips the immune system of its ability to fight infections by destroying the very cells responsible for coordinating immune defense. The primary target is a type of white blood cell called a CD4 cell (also known as a helper T cell), which acts as the immune system’s command center. A healthy person has between 500 and 1,500 CD4 cells per milliliter of blood. An AIDS diagnosis comes when that count drops below 200, leaving the body unable to defend against infections it would normally handle with ease.
But the damage goes far beyond just losing CD4 cells. HIV, the virus that causes AIDS, disrupts nearly every branch of the immune system, from the cells that produce antibodies to the tissues where immune cells develop and communicate. Understanding how this happens explains why AIDS makes the body vulnerable to such a wide range of diseases.
How HIV Gets Inside Immune Cells
HIV specifically targets CD4 cells because the virus uses proteins on the CD4 cell’s surface as a doorway. The outer envelope of the virus fuses with the cell membrane, allowing HIV’s genetic material to slip inside. Once in, the virus converts its RNA into DNA using a specialized enzyme, then inserts that DNA directly into the cell’s own genetic code. The cell essentially becomes a factory for producing new copies of the virus. Those new viral particles push out through the cell membrane (a process called budding), mature into infectious virus, and spread to infect more CD4 cells.
This cycle repeats billions of times a day in an untreated person. Each round of replication damages or destroys the host cell and seeds infection throughout the body.
How CD4 Cells Are Destroyed
For years, scientists assumed that most CD4 cell death came from the virus directly killing cells it had infected. The picture turns out to be more complex and more destructive. Research published through the CDC found that direct viral killing accounts for only a small fraction of CD4 cell loss. Those deaths occur in activated, productively infected cells through a relatively quiet form of cell death.
The far greater damage happens to bystander cells. Over 95% of CD4 cells that die during HIV infection are resting cells in lymphoid tissue that the virus attempts to infect but fails to fully hijack. These abortive infections trigger a violently inflammatory form of cell death called pyroptosis. Unlike quiet cell death, pyroptosis causes the cell to burst open, spilling its contents and inflammatory signals into the surrounding tissue. Those signals attract more CD4 cells to the area, which then become targets themselves, creating a vicious cycle of inflammation and cell death.
This means HIV doesn’t need to successfully infect every CD4 cell to destroy it. The failed attempts are actually more lethal to the overall CD4 population than the successful ones.
Damage to Antibody-Producing Cells
CD4 cells aren’t the only immune cells that suffer. B cells, which are responsible for producing antibodies against bacteria, viruses, and other pathogens, also lose their effectiveness during HIV infection. NIH researchers discovered that in certain people living with HIV, a type of antibody called IgG3 essentially blocks B cells from doing their job. Normally, B cells detect a foreign invader through surface receptors, then produce antibodies to tag that invader for destruction. IgG3 docks onto those receptors and prevents them from responding to threats.
This appears to be the body’s attempt to dial down immune overactivation caused by chronic HIV infection. The immune system is stuck in a paradox: it’s constantly stimulated by the presence of HIV, which causes harmful levels of inflammation, so it develops mechanisms to dampen the response. But those same mechanisms also suppress the immune system’s ability to fight other infections. The result is a person who becomes increasingly vulnerable to pathogens their B cells would normally neutralize. Notably, this IgG3 interference stops when a person begins effective antiviral treatment, confirming that it’s driven directly by the ongoing presence of the virus.
Natural Killer Cells Lose Their Edge
The immune system has a frontline defense force called natural killer (NK) cells. These cells don’t need prior exposure to a pathogen to attack. They’re designed to recognize and destroy infected or abnormal cells on sight. NK cells are reasonably effective at killing HIV-infected CD4 cells, but HIV-infected macrophages (another type of immune cell that the virus can hide in) are a different story.
Research shows that when NK cells encounter HIV-infected macrophages, their response shifts away from killing and toward producing inflammatory signals instead. Even when antibodies are present to help flag infected macrophages for destruction, the killing response remains muted compared to how NK cells handle infected CD4 cells. This allows HIV-infected macrophages to survive and act as long-term reservoirs for the virus, sustaining the infection even when other viral hiding spots are under control.
Scarring of Lymphoid Tissue
Some of the most lasting damage HIV causes happens in the lymph nodes, spleen, thymus, and gut lining, collectively known as lymphoid tissue. These tissues are where immune cells are born, trained, and organized to mount responses against infections. The chronic inflammation driven by HIV triggers a buildup of scar tissue (fibrosis) within these organs. This fibrosis physically disrupts the internal architecture that immune cells depend on to move around, receive survival signals, and coordinate attacks.
Studies in animal models show a strong correlation between the degree of scarring in lymphoid tissue and the severity of immune cell depletion. CD4 cells in the thymus and macrophages in the spleen both decline in proportion to how much collagen (scar tissue) accumulates. This structural damage helps explain why the immune system sometimes can’t fully recover even after the virus is controlled with treatment. The scaffolding that immune cells need has been physically remodeled, and it remains unclear whether this fibrosis is fully reversible even with years of therapy.
What Happens Without Treatment
As CD4 counts fall, infections that a healthy immune system suppresses effortlessly begin to take hold. These are called opportunistic infections, and they emerge in a roughly predictable pattern tied to CD4 levels. When CD4 counts drop below 200, a fungal lung infection called Pneumocystis pneumonia becomes a major threat, along with oral yeast infections. Below 100, parasitic brain infections like toxoplasmosis and viral infections like cytomegalovirus (which can cause blindness) become risks. Below 50, a bacterial infection called Mycobacterium avium complex can spread throughout the body.
Without treatment, people with AIDS typically survive about three years. Once a dangerous opportunistic infection develops, that drops to about one year.
Limits of Immune Recovery With Treatment
Modern antiviral therapy can suppress HIV to undetectable levels in the blood and allow CD4 counts to rise. But recovery has real limits, especially if treatment starts late. Roughly half of treated patients never get their CD4 count back above 500 cells per milliliter, and up to 16% don’t reach even 200 despite years of treatment. About one in five patients experiences what’s called immunologic non-response, where CD4 counts barely budge despite the virus being fully suppressed.
Several factors explain this incomplete recovery. The fibrosis in lymphoid tissue blocks new T cells from accessing the survival signals they need, leading to their premature death. Chronic immune activation persists even on treatment, continuing to exhaust immune cells. And in the gut lining, where a large share of the body’s immune cells reside, CD4 restoration can remain incomplete even after five or more years on therapy.
Starting treatment early, before significant CD4 depletion and tissue damage occurs, produces dramatically better outcomes. Early treatment preserves lymphoid tissue architecture, limits the cycle of inflammation, and prevents the deep immune dysfunction that becomes difficult to reverse. This is the strongest argument for early HIV diagnosis and immediate treatment: not just to prevent AIDS, but to protect the structural foundation the immune system needs to function for life.